Pharma Partnering Summit 2026 returns as the leading global BD&L forum for pharma and biotech, with flagship events in San Diego (29-30 April 2026) and Basel (20-21 May 2026). Meet senior deal-makers through pre-scheduled 1:1 partnering, showcases, expert panels, and high-value networking focused on licensing, collaborations, M&A, and investment. Registration and sponsorship are now open.
The Pharma Partnering Summit 2026 announces its highly anticipated return as the premier global forum dedicated exclusively to Business Development & Licensing (BD&L) in the pharmaceutical and biotechnology sectors. With flagship events planned in Basel, Switzerland (20–21 May 2026) and San Diego, California (29–30 April 2026), it will deliver an unrivaled platform for deal-makers, senior executives, investors, and innovators seeking strategic partnerships, licensing opportunities, and capital engagement worldwide.
Across both EU and US editions, Pharma Partnering Summit is focused on practical BD&L outcomes, connecting companies actively pursuing collaborations in licensing, research partnerships, joint ventures, M&A, external innovation, investment and fundraising.
A Strategic Summit for Global BD&L Professionals
In today’s competitive landscape, pharma and biotech organizations must accelerate innovation by forging the right collaborations at the right time. Pharma Partnering Summit is built to support those needs through:
- Targeted Partnering: Pre-arranged one-to-one partnering meetings with senior decision-makers to explore licensing deals, co-development opportunities, and investment partnerships.
- Showcase Presentations: Focused company presentations to pitch assets, platforms, and technologies to an audience of qualified BD&L professionals.
- Expert Panels: Insights from industry leaders on structuring deals, emerging therapeutic trends, market dynamics, and global partnering strategies.
- Networking Sessions: Dedicated networking time throughout both events to build long-term relationships with potential collaborators and funding partners.
Who Should Attend
- Pharma Partnering Summit is designed for:
- Senior BD&L professionals from pharma and biotech
- Alliance management and external innovation leads
- Investors, VCs, and corporate development teams
- Companies seeking licensing partners or investment
- Technology licensors and asset owners seeking commercialization pathways
- Legal, IP and commercialization strategists
Registration and Opportunities
Registration, sponsorship, and presentation opportunities for both Pharma Partnering Summit EU & USA 2026 are now open.
Join pharma and biotech leaders shaping the next wave of global BD&L outcomes. Visit https://pharma-partnering-summit.com/registration.html to secure your place.
Comments (0)